Suspected interaction of oprelvekin (rhIL-11) with a long-acting opioid

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 837-

  Moorehead, Paul ^a   Mandel, Karen M ^a   Johnston, Donna L ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTINEOPLASTIC AGENT; DAPSONE; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; M ESLON; MORPHINE; PHENOBARBITAL; RECOMBINANT INTERLEUKIN 11; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LUNG TUMOR; NEPHRECTOMY; NEPHROBLASTOMA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SOMNOLENCE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; FEMALE; HUMANS; INTERLEUKIN-11; KIDNEY NEOPLASMS; MORPHINE; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; WILMS TUMOR;

EID: 56749132090     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21719     Document Type: Letter

References (5)

1. Reynolds CH. Clinical efficacy of rhIL-11. Oncology (Williston Park) 2000;14:32-40.
2. Gibson PJ, Vadeboncoeur CM, Johnston DL. Relapse of Wilms' tumor 13 years after original diagnosis. J Pediatr Hematol Oncol 2002;24:192-198.
3. Ault K, Mitchell J, Knowles C. Recombinant human interleukin eleven (Neumega rhIL-11 growth factor) increases plasma volume and decreases urine-sodium excretion in normal human subjects (abstract). Blood 1994;84:276a.
4. Dykstra K, Rogge H, Stone A, et al. Effect of diuretic treatment on rhIL-11-induced salt and water retention (abstract). Blood 1996;88:346a.
5. Brunton LL, editor. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th edition. U.S.A.: McGraw-Hill; 2006.